Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomi... by Molina, Jean-Michel, Dr, LaMarca, Anthony, MD, Andrade-Villanueva, Jaime, MSc, Clotet, Bonaventura, MD, Clumeck, Nathan, MD, Liu, Ya-Pei, PhD, Zhong, Lijie, PhD, Margot, Nicolas, MA, Cheng, Andrew K, MD, Chuck, Steven L, MD

Get full text

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial by Bergenstal, Richard M, Dr, Wysham, Carol, MD, MacConell, Leigh, PhD, Malloy, Jaret, PhD, Walsh, Brandon, PhD, Yan, Ping, PhD, Wilhelm, Ken, MD, Malone, Jim, MD, Porter, Lisa E, MD

Get full text